BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28714407)

  • 1. Update of Standard Practices for New Method Validation in Forensic Toxicology.
    Wille SMR; Coucke W; De Baere T; Peters FT
    Curr Pharm Des; 2017; 23(36):5442-5454. PubMed ID: 28714407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology.
    Scientific Working Group for Forensic Toxicology
    J Anal Toxicol; 2013 Sep; 37(7):452-74. PubMed ID: 23934984
    [No Abstract]   [Full Text] [Related]  

  • 3. Accuracy profile validation of a new analytical method for propane measurement using headspace-gas chromatography-mass spectrometry.
    Smith F; Augsburger M; Varlet V
    J Anal Toxicol; 2014 Mar; 38(2):73-9. PubMed ID: 24327620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in validation, risk and uncertainty assessment of bioanalytical methods.
    Rozet E; Marini RD; Ziemons E; Boulanger B; Hubert P
    J Pharm Biomed Anal; 2011 Jun; 55(4):848-58. PubMed ID: 21237607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good Practices in Forensic Toxicology.
    Drummer OH
    Curr Pharm Des; 2017; 23(36):5437-5441. PubMed ID: 28677500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Neogen ELISA Benzodiazepine Kit using Clonazepam as the Target Molecule for Blood and Urine.
    Behnke G; Tiscione NB; Rakus J; Richards-Waugh L
    J Anal Toxicol; 2019 Jun; 43(5):399-405. PubMed ID: 30877805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry.
    Kadian N; Raju KS; Rashid M; Malik MY; Taneja I; Wahajuddin M
    J Pharm Biomed Anal; 2016 Jul; 126():83-97. PubMed ID: 27179186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of Forensic Toxicology, Yesterday, Today and in the Future.
    Chung H; Choe S
    Curr Pharm Des; 2017; 23(36):5429-5436. PubMed ID: 28641536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations regarding the validation of chromatographic mass spectrometric methods for the quantification of endogenous substances in forensics.
    Hess C; Sydow K; Kueting T; Kraemer M; Maas A
    Forensic Sci Int; 2018 Feb; 283():150-155. PubMed ID: 29301115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation in pharmaceutical analysis. Part II: Central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data.
    Ermer J; Ploss HJ
    J Pharm Biomed Anal; 2005 Apr; 37(5):859-70. PubMed ID: 15862659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on updates, clarifications and controversies in chromatographic assay guidance for bioanalytical method validation from major regulatory agencies and organizations.
    King K; Li P; Pietrasiewicz A; Goldstein S
    Biomed Chromatogr; 2021 Jan; 35(1):e5030. PubMed ID: 33201529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches?
    Wille SMR; Desharnais B; Pichini S; Trana AD; Busardò FP; Wissenbach DK; Peters FT
    Curr Pharm Des; 2022; 28(15):1230-1244. PubMed ID: 35619258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dried blood spots combined to an UPLC-MS/MS method for the simultaneous determination of drugs of abuse in forensic toxicology.
    Sadler Simões S; Castañera Ajenjo A; Dias MJ
    J Pharm Biomed Anal; 2018 Jan; 147():634-644. PubMed ID: 28292561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation in pharmaceutical analysis. Part I: an integrated approach.
    Ermer J
    J Pharm Biomed Anal; 2001 Mar; 24(5-6):755-67. PubMed ID: 11248468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples.
    Nowatzke W; Woolf E
    AAPS J; 2007 Apr; 9(2):E117-22. PubMed ID: 17614353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryover.
    Lowes S; Jersey J; Shoup R; Garofolo F; Needham S; Couerbe P; Lansing T; Bhatti M; Sheldon C; Hayes R; Islam R; Lin Z; Garofolo W; Moussallie M; Teixeira Lde S; Rocha T; Jardieu P; Truog J; Lin J; Lundberg R; Breau A; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Jenkins R; Nicholson R; Lin MH; Karnik S; DeMaio W; Smith K; Cojocaru L; Allen M; Fatmi S; Sayyarpour F; Malone M; Fang X
    Bioanalysis; 2012 Apr; 4(7):763-8. PubMed ID: 22512795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building Bridges between Clinical and Forensic Toxicology Laboratories.
    Barcelo B; Noce V; Gomila I
    Curr Pharm Biotechnol; 2018; 19(2):99-112. PubMed ID: 29745329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method Development in Forensic Toxicology.
    Peters FT; Wissenbach DK; Busardo FP; Marchei E; Pichini S
    Curr Pharm Des; 2017; 23(36):5455-5467. PubMed ID: 28641530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Advances and Future Developments in Forensic Toxicology: From Standard Practices to New Psychoactive Substances.
    Busardo FP; Pichini S; Peters FT
    Curr Pharm Des; 2017; 23(36):5427-5428. PubMed ID: 29237370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.